查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1939341

2026年全球可生物分解止血劑市場報告

Biodegradable Hemostat Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，可生物分解止血劑市場發展迅速，預計將從2025年的9.7億美元成長到2026年的10.8億美元，複合年成長率達11.3%。過去的成長可歸因於多種因素，例如對傳統不可吸收止血劑的依賴、外科手術數量的增加、醫院基礎設施的擴建、止血意識提升以及基本創傷護理技術的普及。

預計未來幾年，可生物分解止血劑市場將快速成長，到2030年市場規模將達到16.3億美元，複合年成長率（CAGR）為10.8%。預測期內的成長主要得益於聚合物和生物材料科學的進步、微創手術數量的增加、創傷和急診病例的增多、可生物分解器械監管核准的增多以及門診手術中心的擴張。預測期內的主要趨勢包括：可吸收止血產品的使用率不斷提高、對生物相容性和生物可吸收材料的偏好日益成長、在微創和腹腔鏡手術中的應用範圍擴大、先進止血劑在創傷和急診護理中的廣泛應用，以及對即用型和便捷型止血劑的需求不斷成長。

預計未來幾年，手術數量的增加將推動可生物分解止血劑市場的成長。手術是一種醫療程序，醫療專業人員使用專用器械出於健康原因治療、修復或切除身體部位。手術數量的增加主要是由於慢性疾病的盛行率上升，這些疾病需要手術介入來控制健康問題並改善患者預後。可生物分解止血劑的優點在於使用後可在體內自然分解，無需取出，並降低術後併發症的風險。例如，根據美國醫療設備製造商Intuitive Surgical Inc.稱，截至2025年1月，2024年美國一般外科手術數量預計將成長約35%，而2023年則成長約42%。在這兩年中，結直腸手術均佔新增手術量的最大比例。因此，手術數量的增加正在推動可生物分解止血劑市場的成長。

生物可分解止血劑市場的主要企業正致力於開發創新解決方案，例如植物來源纖維素基質，以實現快速止血並減少出血。植物來源纖維素基質是由植物纖維製成的可生物分解材料。它們提供天然支撐，並能被人體安全吸收，因此適用於醫療應用。 2024年4月，美國醫療設備製造商Life Science Plus推出了Donor Seal，這是一種完全植物來源纖維素製成的獨特止血敷料。 Donor Seal接觸血液後會轉化為凝膠，有效止血。它還具有完全生物分解、可吸收、無毒和pH值中性等優點，因此對服用抗凝血劑的患者安全。此外，它還能營造濕潤溫和的環境，促進組織自然癒合。這種敷料易於移除，不會撕裂或黏附傷口，從而提高供體部位的舒適度並促進康復。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球可生物分解止血劑市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 永續性、氣候技術和循環經濟
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 可吸收止血產品的應用日益廣泛
    • 人們越來越傾向於選擇生物相容性和生物可吸收性材料。
    • 在微創和腹腔鏡手術中應用日益廣泛
    • 拓展創傷和急診醫學中的先進止血劑應用
    • 對即用型、易於使用的止血劑的需求日益成長

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 診所
  • 創傷與急診醫療中心
  • 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球可生物分解止血劑市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球可生物分解止血劑市場規模、比較及成長率分析
  • 全球可生物分解止血劑市場表現：規模與成長，2020-2025年
  • 全球可生物分解止血劑市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 天然聚合物止血劑、合成聚合物止血劑、複方止血劑、纖維素止血劑、明膠止血劑
  • 配方
  • 粉狀止血劑、顆粒狀止血劑、液體止血劑、泡沫止血劑、薄膜或片狀止血劑
  • 透過使用
  • 外科手術、創傷護理、牙科手術、腹腔鏡手術及其他應用
  • 透過分銷管道
  • 直銷商、經銷商、電子商務平台、藥品零售商、醫療用品公司
  • 最終用戶
  • 醫院、門診手術中心、診所、實驗室和其他終端用戶
  • 按類型細分：天然聚合物止血劑
  • 膠原蛋白蛋白基、幾丁聚醣基、藻酸鹽基、纖維蛋白基、聚葡萄糖基
  • 按類型細分：合成聚合物止血劑
  • 聚乙二醇（PEG）基、聚氨酯基、聚乳酸（PLA）基、聚乙醇酸（PGA）基、聚己內酯（PCL）基
  • 按類型細分：複合止血劑
  • 天然及合成聚合物共混物、聚合物-纖維素複合材料、聚合物-明膠複合材料、多層複合材料、奈米複合止血劑
  • 按類型細分：纖維素基止血劑
  • 氧化再生纖維素（ORC）、微晶纖維素（MCC）、羧甲基纖維素（CMC）、奈米纖維素、羥丙基纖維素（HPC）
  • 按類型細分：明膠類止血劑
  • 豬源明膠基料、牛源明膠基料、魚源明膠基料、交聯明膠、改質明膠製劑

第10章 區域與國家分析

  • 全球可生物分解止血劑市場：按地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球可生物分解止血劑市場：依國家、性能及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 生物分解止血劑市場：競爭格局及市場佔有率（2024年）
  • 生物可分解止血劑市場：公司估值矩陣
  • 生物可分解止血劑市場：公司概況
    • Johnson And Johnson Services Inc
    • Medtronic Plc
    • Stryker Corporation
    • Baxter International Inc
    • Meril Life Sciences Pvt Ltd

第37章：其他領先和創新企業

  • Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, CR Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年可生物分解止血劑市場：提供新機會的國家
  • 2030年可生物分解止血劑市場：充滿新機會的細分市場
  • 2030年可生物分解止血劑市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MBHEM01_G26Q1

A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body's natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.

The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.

Tariffs are impacting the biodegradable hemostat market by increasing costs for imported raw materials such as natural polymers, synthetic biomaterials, and specialized manufacturing inputs. Product segments like composite and synthetic polymer-based hemostats are most affected, particularly in Asia-Pacific and Europe where cross-border sourcing is common. These cost pressures have influenced pricing and supply chain strategies for manufacturers. However, tariffs have also encouraged local sourcing, domestic production, and innovation in alternative biodegradable materials, supporting long-term market growth.

The biodegradable hemostat market research report is one of a series of new reports from The Business Research Company that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.97 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to reliance on conventional non-absorbable hemostats, growing surgical procedure volumes, increasing hospital infrastructure, rising awareness of blood loss management, adoption of basic wound care technologies.

The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in polymer and biomaterial science, growth in minimally invasive surgical procedures, rising trauma and emergency cases, increasing regulatory approvals for biodegradable devices, expansion of ambulatory surgical centers. Major trends in the forecast period include rising adoption of absorbable hemostatic products, growing preference for biocompatible and bioabsorbable materials, increasing use in minimally invasive and laparoscopic surgeries, expansion of advanced hemostats in trauma and emergency care, higher demand for ready-to-use and easy-to-apply hemostats.

The rising number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market in the coming years. Surgical procedures are medical interventions carried out by healthcare professionals using specialized instruments to treat, repair, or remove parts of the body for health-related reasons. The growth in surgical procedures is primarily due to the increasing prevalence of chronic conditions, which often require surgical intervention to manage health problems and enhance patient outcomes. Biodegradable hemostats provide a benefit in surgeries, as they naturally degrade within the body after use, eliminating the need for removal and reducing the risk of post-surgical complications. For example, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following a growth of around 42% in 2023. Colorectal procedures contributed the largest share of additional volume in both years. Consequently, the increasing number of surgical procedures is fueling the growth of the biodegradable hemostat market.

Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.

In March 2023, Medtrade Products Ltd, a UK-based biotechnology firm specializing in haemostasis, wound care, and trauma solutions, collaborated with Laubscher and Co AG to launch the CELOX PPH uterine haemostatic tamponade solution throughout Switzerland to tackle postpartum haemorrhage. Through this partnership, Medtrade aims to broaden access to its advanced haemostat technologies, enhance its presence in the Swiss market, and contribute to better maternal outcomes through rapid and effective bleeding management. Laubscher and Co AG is a Switzerland-based medical device company focusing on surgical and women's health solutions.

Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc

North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Hemostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biodegradable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable hemostat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Natural Polymer-Based Hemostats; Synthetic Polymer-Based Hemostats; Composite Hemostats; Cellulose-Based Hemostats; Gelatin-Based Hemostats
  • 2) By Formulation: Powdered Hemostats; Granular Hemostats; Liquid Hemostats; Foam Hemostats; Film Or Sheet Hemostats
  • 3) By Application: Surgical Procedures; Trauma Procedures; Dental Procedures; Laparoscopic Procedures; Other Applications
  • 4) By Distribution Channel: Direct Sales; Distributors; E-Commerce Platforms; Pharmaceutical Retailers; Healthcare Supply Companies
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Research Laboratories; Other End Users
  • Subsegments:
  • 1) By Natural Polymer-Based Hemostats: Collagen-Based; Chitosan-Based; Alginate-Based; Fibrin-Based; Dextran-Based
  • 2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based; Polyurethane-Based; Polylactic Acid (PLA)-Based; Polyglycolic Acid (PGA)-Based; Polycaprolactone (PCL)-Based
  • 3) By Composite Hemostats: Natural-Synthetic Polymer Blends; Polymer-Cellulose Composites; Polymer-Gelatin Composites; Multi-Layer Composites; Nano-Composite Hemostats
  • 4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC); Microcrystalline Cellulose (MCC); Carboxymethyl Cellulose (CMC); Nanocellulose-Based; Hydroxypropyl Cellulose (HPC)
  • 5) By Gelatin-Based Hemostats: Porcine Gelatin-Based; Bovine Gelatin-Based; Fish Gelatin-Based; Cross-Linked Gelatin; Modified Gelatin Formulations
  • Companies Mentioned: Johnson And Johnson Services Inc; Medtronic Plc; Stryker Corporation; Baxter International Inc; Meril Life Sciences Pvt Ltd; Samyang Holdings Corp; Molnlycke Health Care AB; GELITA Medical GmbH; B Braun Melsungen AG; Tricol Biomedical Inc; Hemostasis LLC; Cura Medical; RevMedx Inc; Speed Care Mineral GmbH; Regenity; C R Bard Inc; Integra LifeSciences Corporation; Advanced Medical Solutions Group plc; Anika Therapeutics Inc; Marine Polymer Technologies Inc; Axio Biosolutions Pvt Ltd; Biom Up Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biodegradable Hemostat Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biodegradable Hemostat Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biodegradable Hemostat Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biodegradable Hemostat Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Sustainability, Climate Tech & Circular Economy
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Absorbable Hemostatic Products
    • 4.2.2 Growing Preference For Biocompatible And Bioabsorbable Materials
    • 4.2.3 Increasing Use In Minimally Invasive And Laparoscopic Surgeries
    • 4.2.4 Expansion Of Advanced Hemostats In Trauma And Emergency Care
    • 4.2.5 Higher Demand For Ready-To-Use And Easy-To-Apply Hemostats

5. Biodegradable Hemostat Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Clinics
  • 5.4 Trauma And Emergency Care Centers
  • 5.5 Research Laboratories

6. Biodegradable Hemostat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biodegradable Hemostat Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biodegradable Hemostat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biodegradable Hemostat Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biodegradable Hemostat Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biodegradable Hemostat Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biodegradable Hemostat Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biodegradable Hemostat Market Segmentation

  • 9.1. Global Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural Polymer-Based Hemostats, Synthetic Polymer-Based Hemostats, Composite Hemostats, Cellulose-Based Hemostats, Gelatin-Based Hemostats
  • 9.2. Global Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Powdered Hemostats, Granular Hemostats, Liquid Hemostats, Foam Hemostats, Film Or Sheet Hemostats
  • 9.3. Global Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Procedures, Trauma Procedures, Dental Procedures, Laparoscopic Procedures, Other Applications
  • 9.4. Global Biodegradable Hemostat Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Sales, Distributors, E-Commerce Platforms, Pharmaceutical Retailers, Healthcare Supply Companies
  • 9.5. Global Biodegradable Hemostat Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Clinics, Research Laboratories, Other End Users
  • 9.6. Global Biodegradable Hemostat Market, Sub-Segmentation Of Natural Polymer-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Collagen-Based, Chitosan-Based, Alginate-Based, Fibrin-Based, Dextran-Based
  • 9.7. Global Biodegradable Hemostat Market, Sub-Segmentation Of Synthetic Polymer-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polyethylene Glycol (PEG)-Based, Polyurethane-Based, Polylactic Acid (PLA)-Based, Polyglycolic Acid (PGA)-Based, Polycaprolactone (PCL)-Based
  • 9.8. Global Biodegradable Hemostat Market, Sub-Segmentation Of Composite Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural-Synthetic Polymer Blends, Polymer-Cellulose Composites, Polymer-Gelatin Composites, Multi-Layer Composites, Nano-Composite Hemostats
  • 9.9. Global Biodegradable Hemostat Market, Sub-Segmentation Of Cellulose-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oxidized Regenerated Cellulose (ORC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Nanocellulose-Based, Hydroxypropyl Cellulose (HPC)
  • 9.10. Global Biodegradable Hemostat Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Porcine Gelatin-Based, Bovine Gelatin-Based, Fish Gelatin-Based, Cross-Linked Gelatin, Modified Gelatin Formulations

10. Biodegradable Hemostat Market Regional And Country Analysis

  • 10.1. Global Biodegradable Hemostat Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biodegradable Hemostat Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biodegradable Hemostat Market

  • 11.1. Asia-Pacific Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biodegradable Hemostat Market

  • 12.1. China Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biodegradable Hemostat Market

  • 13.1. India Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biodegradable Hemostat Market

  • 14.1. Japan Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biodegradable Hemostat Market

  • 15.1. Australia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biodegradable Hemostat Market

  • 16.1. Indonesia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biodegradable Hemostat Market

  • 17.1. South Korea Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biodegradable Hemostat Market

  • 18.1. Taiwan Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biodegradable Hemostat Market

  • 19.1. South East Asia Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biodegradable Hemostat Market

  • 20.1. Western Europe Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biodegradable Hemostat Market

  • 21.1. UK Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biodegradable Hemostat Market

  • 22.1. Germany Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biodegradable Hemostat Market

  • 23.1. France Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biodegradable Hemostat Market

  • 24.1. Italy Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biodegradable Hemostat Market

  • 25.1. Spain Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biodegradable Hemostat Market

  • 26.1. Eastern Europe Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biodegradable Hemostat Market

  • 27.1. Russia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biodegradable Hemostat Market

  • 28.1. North America Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biodegradable Hemostat Market

  • 29.1. USA Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biodegradable Hemostat Market

  • 30.1. Canada Biodegradable Hemostat Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biodegradable Hemostat Market

  • 31.1. South America Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biodegradable Hemostat Market

  • 32.1. Brazil Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biodegradable Hemostat Market

  • 33.1. Middle East Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biodegradable Hemostat Market

  • 34.1. Africa Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biodegradable Hemostat Market Regulatory and Investment Landscape

36. Biodegradable Hemostat Market Competitive Landscape And Company Profiles

  • 36.1. Biodegradable Hemostat Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biodegradable Hemostat Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biodegradable Hemostat Market Company Profiles
    • 36.3.1. Johnson And Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Baxter International Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Meril Life Sciences Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Biodegradable Hemostat Market Other Major And Innovative Companies

  • Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc

38. Global Biodegradable Hemostat Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biodegradable Hemostat Market

40. Biodegradable Hemostat Market High Potential Countries, Segments and Strategies

  • 40.1 Biodegradable Hemostat Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biodegradable Hemostat Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biodegradable Hemostat Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer